Logo image of CGA

CHINA GREEN AGRICULTURE INC (CGA) Stock Fundamental Analysis

NYSE:CGA - US16943W2044 - Common Stock

1.98 USD
+0.01 (+0.51%)
Last: 11/25/2024, 8:04:00 PM
2 USD
+0.02 (+1.01%)
After Hours: 11/25/2024, 8:04:00 PM
Fundamental Rating

1

Overall CGA gets a fundamental rating of 1 out of 10. We evaluated CGA against 84 industry peers in the Chemicals industry. CGA may be in some trouble as it scores bad on both profitability and health. CGA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CGA has reported negative net income.
CGA had a negative operating cash flow in the past year.
CGA had negative earnings in each of the past 5 years.
In the past 5 years CGA always reported negative operating cash flow.
CGA Yearly Net Income VS EBIT VS OCF VS FCFCGA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CGA's Return On Assets of -16.58% is on the low side compared to the rest of the industry. CGA is outperformed by 87.06% of its industry peers.
CGA has a worse Return On Equity (-27.63%) than 84.71% of its industry peers.
Industry RankSector Rank
ROA -16.58%
ROE -27.63%
ROIC N/A
ROA(3y)-24.98%
ROA(5y)-31.96%
ROE(3y)-37.32%
ROE(5y)-45.57%
ROIC(3y)N/A
ROIC(5y)N/A
CGA Yearly ROA, ROE, ROICCGA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Gross Margin of CGA (20.99%) is worse than 61.18% of its industry peers.
In the last couple of years the Gross Margin of CGA has remained more or less at the same level.
CGA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y-1.28%
CGA Yearly Profit, Operating, Gross MarginsCGA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

CGA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CGA has been increased compared to 1 year ago.
CGA has more shares outstanding than it did 5 years ago.
CGA has a worse debt/assets ratio than last year.
CGA Yearly Shares OutstandingCGA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CGA Yearly Total Debt VS Total AssetsCGA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

CGA has an Altman-Z score of -0.29. This is a bad value and indicates that CGA is not financially healthy and even has some risk of bankruptcy.
CGA has a worse Altman-Z score (-0.29) than 83.53% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that CGA is not too dependend on debt financing.
CGA's Debt to Equity ratio of 0.11 is amongst the best of the industry. CGA outperforms 84.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACC6.78%
CGA Yearly LT Debt VS Equity VS FCFCGA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CGA has a Current Ratio of 2.04. This indicates that CGA is financially healthy and has no problem in meeting its short term obligations.
CGA has a Current ratio of 2.04. This is comparable to the rest of the industry: CGA outperforms 45.88% of its industry peers.
CGA has a Quick Ratio of 1.48. This is a normal value and indicates that CGA is financially healthy and should not expect problems in meeting its short term obligations.
CGA has a Quick ratio of 1.48. This is comparable to the rest of the industry: CGA outperforms 55.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.48
CGA Yearly Current Assets VS Current LiabilitesCGA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

0

3. Growth

3.1 Past

CGA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -83.20%.
The Revenue for CGA has decreased by -23.65% in the past year. This is quite bad
Measured over the past years, CGA shows a very negative growth in Revenue. The Revenue has been decreasing by -20.10% on average per year.
EPS 1Y (TTM)-83.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
Revenue 1Y (TTM)-23.65%
Revenue growth 3Y-19.14%
Revenue growth 5Y-20.1%
Sales Q2Q%-22.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CGA Yearly Revenue VS EstimatesCGA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CGA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CGA Price Earnings VS Forward Price EarningsCGA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGA Per share dataCGA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA GREEN AGRICULTURE INC

NYSE:CGA (11/25/2024, 8:04:00 PM)

After market: 2 +0.02 (+1.01%)

1.98

+0.01 (+0.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-18 2024-11-18
Earnings (Next)02-07 2025-02-07
Inst Owners0.14%
Inst Owner Change11.8%
Ins Owners84.23%
Ins Owner Change0%
Market Cap29.28M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.33
EV/EBITDA N/A
EPS(TTM)-1.99
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS6.14
BVpS6.96
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.58%
ROE -27.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.99%
FCFM N/A
ROA(3y)-24.98%
ROA(5y)-31.96%
ROE(3y)-37.32%
ROE(5y)-45.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.39%
GM growth 5Y-1.28%
F-Score2
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.35%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.48
Altman-Z -0.29
F-Score2
WACC6.78%
ROIC/WACCN/A
Cap/Depr(3y)41.14%
Cap/Depr(5y)27.6%
Cap/Sales(3y)0.98%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-83.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.65%
Revenue growth 3Y-19.14%
Revenue growth 5Y-20.1%
Sales Q2Q%-22.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.75%
OCF growth 3YN/A
OCF growth 5YN/A